<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00629304</url>
  </required_header>
  <id_info>
    <org_study_id>DCIC 07 08</org_study_id>
    <nct_id>NCT00629304</nct_id>
  </id_info>
  <brief_title>Multicenter Assessment of the PDA-FIT System in Type 1 Diabetic Patients</brief_title>
  <acronym>TELEDIAB-1</acronym>
  <official_title>Multicenter Assessment of the PDA-FIT System in Type 1 Diabetic Patients With Chronic Failure of Intensive Insulin Therapy and Conventional Care. The TELEDIAB-1 STUDY</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre d’Etudes et de Recherche pour l’Intensification du Traitement du Diabète</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre d’Etudes et de Recherche pour l’Intensification du Traitement du Diabète</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      TELEDIAB-1 is a national, multicenter, controlled, randomised trial. The Primary objective of
      the TELEDIAB-1 study is to demonstrate that the PDA-FIT system (PDA-Phone and/or
      telemonitoring) is able to improve metabolic control of chronically uncontrolled type 1
      diabetic patients, despite intensive insulin therapy (multiple daily injections with
      basal-bolus insulin or insulin pump), as compared with conventional care.

      Main judgment criteria: comparison of HbA1c means between the 3 groups at 6 months
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Secondary Objectives :

        1. To assess the improvement of blood glucose control and quality of life in patients using
           the PDA-FIT system

        2. To assess the improvement in diabetes care provided by the use of the PDA-FIT system

        3. Satisfaction of patients and physicians towards the PDA-FIT system
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2007</start_date>
  <completion_date type="Actual">August 2009</completion_date>
  <primary_completion_date type="Actual">March 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of HbA1c mean between the 3 groups</measure>
    <time_frame>at 6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Absolute HbA1c differences (M0-M6)</measure>
    <time_frame>inclusion and M6</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HbA1c changes at M0, M3 and M6</measure>
    <time_frame>inclusion, M3 and M6</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients reaching HbA1c &lt;7.5% at 6 months</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean of blood glucose values as provided by glucose meters during the 14 days prior to inclusion and prior to the 6 months-visit</measure>
    <time_frame>14 days prior to inclusion and prior to M6</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of severe hypoglycaemic episodes and ketoacidosis episodes during the study period</measure>
    <time_frame>study period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of symptomatic benign hypoglycaemic episodes during the week prior to inclusion and prior to the 6 months-visit</measure>
    <time_frame>week before inclusion and prior to M6</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>8-point blood glucose profiles at inclusion and 6 months</measure>
    <time_frame>inclusion and M6</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life at inclusion and 6 months, using the DHP scale and the Satisfaction item of the DQOL questionnaire</measure>
    <time_frame>inclusion and M6</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement in diabetes care, as assessed by the change in blood glucose testing frequency, reflected by the glucose meter memory</measure>
    <time_frame>study period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time spent by physicians with patients during visits (either face to face visits or phone call visits) and time spent by patients during transport, waiting time and lost working time</measure>
    <time_frame>study period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction of patients and physicians with the system and willingness to carry on the use of the system in routine care</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effective number of patients carrying on the use of the system in routine care, at their own expense and in agreement with their physician</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">180</enrollment>
  <condition>Type 1 Diabetes</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>standard visit at 3 and 6 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>PDA-FIT system + standard visit at 3 and 6 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>PDA-FIT system + 12 telephone visits + standard visit at 6 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>Patients will have face to face visits at 3 and 6 months and no PDA-FIT system. Patients will record glycemia on paper support.</description>
    <arm_group_label>1</arm_group_label>
    <other_name>paper support for glycemia</other_name>
    <other_name>face to face visits at 3 and 6 months</other_name>
    <other_name>without PDA-FIT system</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>VISITS + PDA-FIT system</intervention_name>
    <description>patients will have face to face visits at 3 and 6 months + PDA-FIT system</description>
    <arm_group_label>2</arm_group_label>
    <other_name>face to face visits at 3 and 6 months</other_name>
    <other_name>PDA-FIT system</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PDA-FIT System + telephone follow-up</intervention_name>
    <description>patients will received PDA-FIT system + a telephone follow up (12 phone calls) and a face to face visit at 6 months</description>
    <arm_group_label>3</arm_group_label>
    <other_name>face to face visit at 6 months</other_name>
    <other_name>telephone visits each 2 weeks</other_name>
    <other_name>PDA-FIT system</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  type 1 diabetes mellitus for ≥ 12 months or more (including C-peptide negative
             secondary diabetes)

          -  age &gt; 18 y.o.

          -  intensive insulin basal-bolus therapy for ≥ 6 months. At inclusion, patients should be
             treated, either with a combination of a basal, long-acting insulin and insulin rapid
             analog before each meal, or with rapid insulin analog delivered with a pump

          -  chronically uncontrolled diabetes with HbA1c ≥ 8 % during the past 12 months and at
             inclusion

        Exclusion Criteria:

          -  patient with unstable associated evolutive pathology

          -  patient who need a more frequent diabetic follow up (than in the protocol)

          -  patient with a education teaching within the 3 months before inclusion

          -  patient with a hemoglobinopathy

          -  patient with toxicomania, alcoholism or psychological troubles

          -  type 2 diabetes patients

          -  patient who don't need strict metabolic objectives

          -  pregnant or parturient women

          -  person with no freedom (prisoner)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pierre Yves BENHAMOU, MD PHD</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospital, Grenoble</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre Hospitalier de Belfort Montbéliard</name>
      <address>
        <city>Belfort</city>
        <zip>90016</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Jean Minjoz</name>
      <address>
        <city>Besancon</city>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH SUD Francilien</name>
      <address>
        <city>Corbeil Essonnes</city>
        <zip>91100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Grenoble</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHRU Lille</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Edouard Herriot</name>
      <address>
        <city>Lyon</city>
        <zip>69003</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Marseille Hôpitaux Sud</name>
      <address>
        <city>Marseille</city>
        <zip>13274</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chu Montpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Hôpital Jeanne d'Arc</name>
      <address>
        <city>Nancy</city>
        <zip>54201</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Nantes</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Hotel Dieu</name>
      <address>
        <city>Paris</city>
        <zip>75004</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital COCHIN</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HOPITAL Saint Louis</name>
      <address>
        <city>Paris</city>
        <zip>75475</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Haut Leveque</name>
      <address>
        <city>Pessac</city>
        <zip>33604</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Rennes</name>
      <address>
        <city>Rennes</city>
        <zip>35056</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Bellevue</name>
      <address>
        <city>Saint Etienne</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Toulouse</name>
      <address>
        <city>Toulouse</city>
        <zip>31403</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 26, 2008</study_first_submitted>
  <study_first_submitted_qc>March 4, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 5, 2008</study_first_posted>
  <last_update_submitted>February 8, 2012</last_update_submitted>
  <last_update_submitted_qc>February 8, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 9, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>type 1 diabetes</keyword>
  <keyword>PDA phone (Personal Digital Assistant)</keyword>
  <keyword>HbA1c</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

